標題: Titlebook: Acute Myeloid Leukemia; Christoph R?llig,Gert J. Ossenkoppele Book 2021 Springer Nature Switzerland AG 2021 Acute Myeloid Leukemia.Genomic [打印本頁] 作者: Capricious 時間: 2025-3-21 17:21
書目名稱Acute Myeloid Leukemia影響因子(影響力)
書目名稱Acute Myeloid Leukemia影響因子(影響力)學科排名
書目名稱Acute Myeloid Leukemia網(wǎng)絡公開度
書目名稱Acute Myeloid Leukemia網(wǎng)絡公開度學科排名
書目名稱Acute Myeloid Leukemia被引頻次
書目名稱Acute Myeloid Leukemia被引頻次學科排名
書目名稱Acute Myeloid Leukemia年度引用
書目名稱Acute Myeloid Leukemia年度引用學科排名
書目名稱Acute Myeloid Leukemia讀者反饋
書目名稱Acute Myeloid Leukemia讀者反饋學科排名
作者: Graves’-disease 時間: 2025-3-21 22:59 作者: cardiopulmonary 時間: 2025-3-22 02:12 作者: 倔強不能 時間: 2025-3-22 04:43
Special Clinical Scenarios: Hyperleukocytosis,iew questions, pearls and pitfalls, and generous illustrations and intra-operative photographs.. Written and edited by thought leaders in the field, this user-friendly?textbook will be an essential resource for orthopedic and neurosurgery trainees, as well as a valuable reference and review for spin作者: synovitis 時間: 2025-3-22 10:35 作者: 殺菌劑 時間: 2025-3-22 16:46
Diagnosis and Classification of AML: WHO 2016,ideration of different reimbursement environments and the different types of glaucoma, e.g. angle closure glaucoma. This book will assist both glaucoma surgeons and general ophthalmologists in overcoming the learning curve involved in performed MIGS, by providing valuable and practical clinical pearls.978-981-15-5634-0978-981-15-5632-6作者: considerable 時間: 2025-3-22 17:20 作者: 輕快來事 時間: 2025-3-22 23:08 作者: 使高興 時間: 2025-3-23 03:28
Treatment of Newly Diagnosed AML in Fit Patients,-percutaneous nephrolithotomy, armamentarium, different techniques, and multiple advances, plus the results including complications...?.This book serves as a valuable resource for urologists dealing with and in978-981-16-6003-0978-981-16-6001-6作者: Optometrist 時間: 2025-3-23 08:48 作者: Prostaglandins 時間: 2025-3-23 13:10 作者: 物種起源 時間: 2025-3-23 14:57 作者: IOTA 時間: 2025-3-23 20:03 作者: 招惹 時間: 2025-3-23 22:21 作者: 哀悼 時間: 2025-3-24 05:34
Book 2021 treatment of acute promyelocytic leukemia, current practice of allogeneic stem cell transplantation, and special clinical situations. Finally, promising approaches in drug development, current standards and challenges in assessment of measurable residual disease, immune approaches, and ideas for in作者: 羽飾 時間: 2025-3-24 08:19
Fuels for High-Performance Flight, inhibitors (e.g., etoposide, doxorubicin), and other drugs (e.g., azathioprine) are described to be associated with the development of therapy-related AML (t-AML). Furthermore, about 5–15% of adults and 4–13% of pediatric patients with MDS or AML carry germline pathogenic variants in cancer suscept作者: Host142 時間: 2025-3-24 12:24 作者: 6Applepolish 時間: 2025-3-24 16:55 作者: 成績上升 時間: 2025-3-24 21:04
Understanding the Basics of Aviation Noise,cytogenetic subgroups and molecular markers such as ., and ., also the screening for ., and . mutations is now recommended. In the future, a better understanding of the clonal evolution leading to malignant transformation and selection of resistant leukemia clones will not only be crucial for refine作者: Initiative 時間: 2025-3-24 23:47
The Unlawful Interference Conventions, therapies of varying intensity and duration have become available to choose the ideal compromise between organ toxicity and reduction of the risk of relapse in most patients up to the age of about 70 with a good performance status. Inclusion of haploidentical donors and the use of more sensitive te作者: 合適 時間: 2025-3-25 05:15
Kuklev E.A.,Shapkin V.S.,Shatrakov Y.G.significant relapse rate attributed to several AML-associated immune escape mechanisms. These include reduced expression of major histocompatibility complex (MHC) molecules, enhanced expression of inhibitory ligands, reduced expression of activating ligands and receptors, and manipulation of soluble作者: 價值在貶值 時間: 2025-3-25 08:39
Acute Myeloid Leukemia978-3-030-72676-8Series ISSN 2197-9766 Series E-ISSN 2197-9774 作者: 符合規(guī)定 時間: 2025-3-25 13:21 作者: ethereal 時間: 2025-3-25 17:52 作者: 合同 時間: 2025-3-25 20:32
Christoph R?llig,Gert J. OssenkoppeleExplanation of diagnostic workup and disease classification.Clear guidance on initial treatment and relapse strategies.Information on optimal use of newly approved agents作者: 使糾纏 時間: 2025-3-26 03:10 作者: Transfusion 時間: 2025-3-26 08:21 作者: 蔓藤圖飾 時間: 2025-3-26 08:42
https://doi.org/10.1007/978-1-349-06904-0 disease course. Due to the significant prognostic role of genetic changes in AML, characterization of molecular and phenotypic profiles is essential to designing patient- and disease-specific strategies aimed at preventing disease relapse and improving long-term outcome. In recent years, deep biolo作者: 反應 時間: 2025-3-26 14:41
https://doi.org/10.1007/978-3-030-91194-2ially at an advanced age. The notion of inheritance, a frequent concern with patients, has traditionally been underappreciated by hematologists. Recent insights stress the relevance of awareness of genetic predisposition. The diagnosis of genetic predisposition has important consequences for the tre作者: Anthropoid 時間: 2025-3-26 18:58 作者: artless 時間: 2025-3-26 23:26
Understanding the Basics of Aviation Noise, translocation described by Janet Rowley in 1972, there has been a growing knowledge on the pathogenic relevance of the genomic aberrations underlying the biological and clinical complexity of AML. Recently, molecular genomics have begun to unravel mechanisms of clonal leukemia evolution and disease作者: 周興旺 時間: 2025-3-27 01:23 作者: 出血 時間: 2025-3-27 07:47 作者: 催眠 時間: 2025-3-27 12:29 作者: SLING 時間: 2025-3-27 15:09 作者: 捕鯨魚叉 時間: 2025-3-27 18:23 作者: 摘要記錄 時間: 2025-3-27 22:49 作者: 宏偉 時間: 2025-3-28 04:17
https://doi.org/10.1007/978-3-642-11703-9plantation have one of the poorest prognoses in onco-hematology with current non-intensive therapies. However, one of the major therapeutic improvements in AML so far was recently achieved in R/R setting through the introduction of novel, rationally designed, small-molecules inhibitors such as FLT3 作者: Recessive 時間: 2025-3-28 10:20
The Unlawful Interference Conventions,timization of donor choice, supportive care, conditioning regimens, and monitoring of residual disease have led to a constant improvement of outcomes. Specifically, more and more patients at higher ages are offered allogeneic HCT as the therapeutic option with the highest curative potential..Most gu作者: 不朽中國 時間: 2025-3-28 12:58
https://doi.org/10.1007/978-3-319-58139-2tically poor leukemia or an independent risk factor has been discussed controversially. Hyperleukocytosis indicates high tumor burden, hence tumor lysis syndrome, coagulopathy, and electrolyte disbalance are associated with the diagnosis, whether from spontaneous tumor cell disintegration or cell de作者: 黃油沒有 時間: 2025-3-28 15:04 作者: 能得到 時間: 2025-3-28 19:52
Other Human Rights in Aviation Securityements in therapeutic options, until recently. A swathe of new drug approvals by the FDA has resulted in a subset of drugs also receiving approval in the European Union (EMA). These drugs have been discussed elsewhere in this book. This chapter will focus on new, non-immune-based therapies which hav作者: Accrue 時間: 2025-3-29 01:23 作者: ALLAY 時間: 2025-3-29 05:06
https://doi.org/10.1007/978-3-030-91194-2aNet (ELN) recommendations (Dohner et al. 2017)..This chapter intends to offer background information on germline predisposition to MN and provide the hematologist with practical guidelines on when to suspect, how to detect, and what to consider in the treatment and follow-up of patients carrying genetic predisposition to MN.作者: 嘮叨 時間: 2025-3-29 10:25
Aviation Noise Impact Management presence of at least 20% of myeloid blasts in BM or PB..Careful genetic assessment, together with evaluations of performance status and comorbidities, is recommended to characterize disease-specific and patient-specific factors providing important information for risk stratification and treatment decisions.作者: PARA 時間: 2025-3-29 12:42
Importance of Fatigue Risk Managemente based on the probability to achieve a response to intensive or investigational salvage therapy. Several new approaches are currently evaluated and matching for controls may help to increase external validity of new approaches evaluated in single arm phase-II clinical trials.作者: 毛細血管 時間: 2025-3-29 18:25 作者: 忍耐 時間: 2025-3-29 19:45 作者: instulate 時間: 2025-3-30 03:05
https://doi.org/10.1007/978-3-642-11703-9able safety profile as compared to what we have learned so long with intensive chemotherapy in R/R AML. Other small molecules targeting BCL2 or TP53, drug combinations, or monoclonal antibodies are also intensively studied in these patients paving the way for significant prognosis improvement in the coming years.作者: 饑荒 時間: 2025-3-30 05:51 作者: debouch 時間: 2025-3-30 11:51 作者: Temporal-Lobe 時間: 2025-3-30 15:59
Book 2021n adults. The opening chapters present current knowledge of epidemiology, etiologic factors, and the pathogenesis and molecular development of AML. Detailed guidance is offered on laboratory and clinical diagnostic workup and disease classification, and the patient- and disease-related factors that 作者: Sinus-Rhythm 時間: 2025-3-30 16:41
Aviation Risk and Safety Managementasured at the diagnosis of AML, with an emphasis on disease-related factors. The role of measurable residual disease and how prognostic stratification affects treatment decisions are covered in other chapters.作者: exquisite 時間: 2025-3-30 21:25 作者: fertilizer 時間: 2025-3-31 02:05
Aviation Risk and Safety Management clinical trials and real-world studies that have provided evidence of the efficacy and effectiveness of HMAs. We discuss HMAs’ specificity regarding biological and clinical effects, potential resistance mechanisms, and the attempts to improve their clinical activity via combination with other treatments.作者: 陰郁 時間: 2025-3-31 05:13
Other Human Rights in Aviation Securitycted in febrile neutropenic patients, a prompt diagnostic work-up and evidence-based empiric antimicrobial intervention are mandatory. In addition to early empiric therapy, the administration of anti-infective prophylaxis is another key to preventing adverse events.作者: 爭論 時間: 2025-3-31 12:27
Diagnosis and Classification of AML: WHO 2016,ations and figures in each chapter.Special section covers th.This open access book covers all aspects of minimally invasive glaucoma surgery (MIGS) and provides detailed information on each MIGS device, including its mechanism of action; patient selection; implantation techniques; post-operative man作者: Hyperlipidemia 時間: 2025-3-31 16:46
Germline Predisposition in AML,plains the role of laparoscopy in gynecologic oncology.WrittIn this book, world-renowned experts describe the latest advances in minimally invasive gynecologic surgery and explain why endoscopy is of key importance in so many conditions. Hysteroscopic instrumentation is described and the application作者: 廣口瓶 時間: 2025-3-31 21:21 作者: Favorable 時間: 2025-3-31 22:41 作者: 斜 時間: 2025-4-1 02:00
Management of Acute Promyelocytic Leukemia,-step descriptions of surgical techniques, supported by numeMinimally invasive techniques, designed to reduce morbidity and risk while simultaneously improving outcomes, are increasingly being used in oral and maxillofacial surgery. This book covers the most recent technological developments and the作者: 飾帶 時間: 2025-4-1 06:49 作者: MORPH 時間: 2025-4-1 13:25 作者: Nmda-Receptor 時間: 2025-4-1 14:51 作者: Restenosis 時間: 2025-4-1 19:20 作者: 創(chuàng)造性 時間: 2025-4-2 00:47
Special Clinical Scenarios: Hyperleukocytosis,in a revised and expanded second edition including 19 new chapters, this comprehensive textbook provides an updated presentation of the field of MISS, highlighting surgical techniques and clinical outcomes as well as providing a unique focus on how these techniques are applied for specific spinal co作者: thrombus 時間: 2025-4-2 06:50
Special Clinical Scenarios: Infectious Complications and Prophylaxis, techniques including evidence-based recommendations and tip.Over the past decade, minimally invasive techniques have developed rapidly and are widely applied in the management of spine disorders. With the development of enabling technologies, including specifically designed spinal retractor systems
